|
1
|
Auffinger B, Tobias AL, Han Y, Lee G, Guo
D, Dey M, Lesniak MS and Ahmed AU: Conversion of differentiated
cancer cells into cancer stem-like cells in a glioblastoma model
after primary chemotherapy. Cell Death Differ. 21:1119–1131. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li C, Lee CJ and Simeone DM:
Identification of human pancreatic cancer stem cells. Methods Mol
Biol. 568:161–173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
10
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peitzsch C, Kurth I, Kunz-Schughart L,
Baumann M and Dubrovska A: Discovery of the cancer stem cell
related determinants of radioresistance. Radiother Oncol.
108:378–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is a molecular
determinant of the side-population phenotype. Nat Med. 7:1028–1034.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldstein LJ, Fojo AT, Ueda K, Crist W,
Green A, Brodeur G, Pastan I and Gottesman MM: Expression of the
multidrug resistance, MDR1, gene in neuroblastomas. J Clin Oncol.
8:128–136. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fukaya R, Ohta S, Yamaguchi M, Fujii H,
Kawakami Y, Kawase T and Toda M: Isolation of cancer stem-like
cells from a side population of a human glioblastoma cell line,
SK-MG-1. Cancer Lett. 291:150–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hadnagy A, Gaboury L, Beaulieu R and
Balicki D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chua C, Zaiden N, Chong KH, See SJ, Wong
MC, Ang BT and Tang C: Characterization of a side population of
astrocytoma cells in response to temozolomide. J Neurosurg.
109:856–866. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu G, Yuan X, Zeng Z, Tunici P, Ng H,
Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene
expression and chemoresistance of CD133+ cancer stem cells in
glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Sakariassen PO, Tsinkalovsky O,
Immervoll H, Boe SO, Svendsen A, Prestegarden L, Rosland G, Thorsen
F, Stuhr L, et al: CD133 negative glioma cells form tumors in nude
rats and give rise to CD133 positive cells. Int J Cancer.
122:761–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schinkel AH, Smit JJ, van Tellingen O,
Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA,
Robanus-Maandag EC, te Riele HP, et al: Disruption of the mouse
mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain
barrier and to increased sensitivity to drugs. Cell. 77:491–502.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou S, Morris JJ, Barnes Y, Lan L,
Schuetz JD and Sorrentino BP: Bcrp1 gene expression is required for
normal numbers of side population stem cells in mice, and confers
relative protection to mitoxantrone in hematopoietic cells in vivo.
Proc Natl Acad Sci USA. 99:12339–12344. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jonker JW, Buitelaar M, Wagenaar E, Van
Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink
RP, Rosing H, et al: The breast cancer resistance protein protects
against a major chlorophyll-derived dietary phototoxin and
protoporphyria. Proc Natl Acad Sci USA. 99:15649–15654. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Platet N, Mayol JF, Berger F, Herodin F
and Wion D: Fluctuation of the SP/non-SP phenotype in the C6 glioma
cell line. FEBS Lett. 581:1435–1440. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitsutake N, Iwao A, Nagai K, Namba H,
Ohtsuru A, Saenko V and Yamashita S: Characterization of side
population in thyroid cancer cell lines: Cancer stem-like cells are
enriched partly but not exclusively. Endocrinology. 148:1797–1803.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Burkert J, Otto WR and Wright NA: Side
populations of gastrointestinal cancers are not enriched in stem
cells. J Pathol. 214:564–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lichtenauer UD, Shapiro I, Geiger K,
Quinkler M, Fassnacht M, Nitschke R, Ruckauer KD and Beuschlein F:
Side population does not define stem cell-like cancer cells in the
adrenocortical carcinoma cell line NCI h295R. Endocrinology.
149:1314–1322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grobben B, De Deyn PP and Slegers H: Rat
C6 glioma as experimental model system for the study of
glioblastoma growth and invasion. Cell Tissue Res. 310:257–270.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou XD, Wang XY, Qu FJ, Zhong YH, Lu XD,
Zhao P, Wang DH, Huang QB, Zhang L and Li XG: Detection of cancer
stem cells from the C6 glioma cell line. J Int Med Res. 37:503–510.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng X, Shen G, Yang X and Liu W: Most C6
cells are cancer stem cells: Evidence from clonal and population
analyses. Cancer Res. 67:3691–3697. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng
X, Wen L and Yang X: Identification of cancer stem-like cells in
the C6 glioma cell line and the limitation of current
identification methods. In Vitro Cell Dev Biol Anim. 44:280–289.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Qu J, Shi Y, Perfetto M, Ping Z,
Christian L, Niu H, Mei S, Zhang Q, Yang X and Wei S: Nicotinic
acid inhibits glioma invasion by facilitating Snail1 degradation.
Sci Rep. 7:431732017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neradil J and Veselska R: Nestin as a
marker of cancer stem cells. Cancer Sci. 106:803–811. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Zhou F, Li Y, Li Q, Wu Z, Yu L,
Yuan F, Liu J, Tian Y, Cao Y, et al: Cdc20 overexpression is
involved in temozolomide-resistant glioma cells with
epithelial-mesenchymal transition. Cell Cycle. 16:2355–2365. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY,
Xie SD and Qi ST: Akt and β-catenin contribute to TMZ resistance
and EMT of MGMT negative malignant glioma cell line. J Neurol Sci.
367:101–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Decleves X, Bihorel S, Debray M, Yousif S,
Camenisch G and Scherrmann JM: ABC transporters and the
accumulation of imatinib and its active metabolite CGP74588 in rat
C6 glioma cells. Pharmacol Res. 57:214–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wee B, Pietras A, Ozawa T, Bazzoli E,
Podlaha O, Antczak C, Westermark B, Nelander S, Uhrbom L,
Forsberg-Nilsson K, et al: ABCG2 regulates self-renewal and stem
cell marker expression but not tumorigenicity or radiation
resistance of glioma cells. Sci Rep. 6:259562016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nigam SK: What do drug transporters really
do? Nat Rev Drug Discov. 14:29–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gupta PB, Fillmore CM, Jiang G, Shapira
SD, Tao K, Kuperwasser C and Lander ES: Stochastic state
transitions give rise to phenotypic equilibrium in populations of
cancer cells. Cell. 146:633–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hemmati HD, Nakano I, Lazareff JA,
Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ligon KL, Huillard E, Mehta S, Kesari S,
Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, Depinho RA, et al:
Olig2-regulated lineage-restricted pathway controls replication
competence in neural stem cells and malignant glioma. Neuron.
53:503–157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y,
Kim CG, Cantor AB and Orkin SH: A Myc network accounts for
similarities between embryonic stem and cancer cell transcription
programs. Cell. 143:313–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tunici P, Bissola L, Lualdi E, Pollo B,
Cajola L, Broggi G, Sozzi G and Finocchiaro G: Genetic alterations
and in vivo tumorigenicity of neurospheres derived from an adult
glioblastoma. Mol Cancer. 3:252004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pastrana E, Silva-Vargas V and Doetsch F:
Eyes wide open: A critical review of sphere-formation as an assay
for stem cells. Cell Stem Cell. 8:486–498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Broadley KW, Hunn MK, Farrand KJ, Price
KM, Grasso C, Miller RJ, Hermans IF and McConnell MJ: Side
population is not necessary or sufficient for a cancer stem cell
phenotype in glioblastoma multiforme. Stem Cells. 29:452–461. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bleau AM, Hambardzumyan D, Ozawa T,
Fomchenko EI, Huse JT, Brennan CW and Holland EC: PTEN/PI3K/Akt
pathway regulates the side population phenotype and ABCG2 activity
in glioma tumor stem-like cells. Cell Stem Cell. 4:226–235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Golebiewska A, Bougnaud S, Stieber D,
Brons NH, Vallar L, Hertel F, Klink B, Schrock E, Bjerkvig R and
Niclou SP: Side population in human glioblastoma is non-tumorigenic
and characterizes brain endothelial cells. Brain. 136:1462–1475.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Quintana E, Shackleton M, Sabel MS, Fullen
DR, Johnson TM and Morrison SJ: Efficient tumour formation by
single human melanoma cells. Nature. 456:593–598. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bissell MJ and Labarge MA: Context, tissue
plasticity, and cancer: Are tumor stem cells also regulated by the
microenvironment? Cancer Cell. 7:17–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
